Times reporting prompts new guidance on high-risk psychiatric drug
- Posted on June 14, 2026
- By The Times
- 2 Views
- 1 min read
Times reporting prompts new guidance on high-risk psychiatric drug
An investigation into clozapine, used in cases of treatment-resistant paranoid schizophrenia, revealed the importance of monitoring its serious side-effects
